Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.

Fiskus W, Sharma S, Qi J, Valenta JA, Schaub LJ, Shah B, Peth K, Portier BP, Rodriguez M, Devaraj SG, Zhan M, Sheng J, Iyer SP, Bradner JE, Bhalla KN.

Mol Cancer Ther. 2014 May;13(5):1142-54. doi: 10.1158/1535-7163.MCT-13-0770. Epub 2014 Jan 16.

2.

Arrested protein synthesis increases persister-like cell formation.

Kwan BW, Valenta JA, Benedik MJ, Wood TK.

Antimicrob Agents Chemother. 2013 Mar;57(3):1468-73. doi: 10.1128/AAC.02135-12. Epub 2013 Jan 7.

Supplemental Content

Loading ...
Support Center